QuickView for gonadotropin hormone-releasing hormone activity (biogroup)

1. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
2. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
3. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
4. L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
5. Omental and subcutaneous adipose tissue taken from patients receiving bariatric surgery

There were no matches for gonadotropin hormone-releasing hormone activity

1. Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol i…
2. Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idio…
3. Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treatin…
4. Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods o…
5. Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogo…